The Global Psychedelic Therapeutics Market is emerging as a transformative segment within the life sciences and mental healthcare industry, driven by rising awareness of alternative therapies and increasing prevalence of mental health disorders. The market is projected to grow significantly from US$ 3.33 billion in 2025 to US$ 11.85 billion by 2034, registering a strong CAGR of 15.14%...